Position in AXSM
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$13,783,733
+$4,211,624 QoQ
Shares Held
56,313
-0.6% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#108
of 503 holders
Holding Since
Dec 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AXSM Over Time
Shares Held
Position Value (USD)
Derivatives in AXSM
reported options exposure · as of Mar 31, 2025CallValue
$1,250
CallShares
200
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $312,855,129 across 115 Biotechnology names. AXSM ranks #7 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
870,551 | $82,484,707 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
64,650 | $40,311,861 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
105,045 | $31,621,696 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
49,020 | $24,349,704 | |
| 5 | RPRX |
Royalty Pharma plc
|
285,630 | $16,015,274 | |
| 6 | EXEL |
Exelixis, Inc.
|
291,162 | $15,842,124 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
This page
|
56,313 | $13,783,733 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
140,394 | $11,443,514 |
All Filings in AXSM
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,783,733 | 56,313 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $9,572,109 | 56,633 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $10,222,726 | 55,972 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $6,936,616 | 57,115 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $1,144,323 | 10,962 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,580,336 | 13,550 | Shares | Sole | 2025-05-13 | |
| 2025-03-31 | $1,250 | 200 | Call | Sole | 2025-05-13 | |
| 2024-12-31 | $1,138,850 | 13,460 | Shares | Sole | 2025-02-07 | |
| 2023-06-30 | $862 | 12 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $199,627 | 2,778 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $256,688 | 3,328 | Shares | Sole | 2023-02-09 | |
| No filing history on record for this holder in this stock. | ||||||